Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-19

Clinical Trial Update: Reducing Systemic Inflammation in People on Antiretroviral Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is currently recruiting to test strategies for reducing systemic inflammation in people living with HIV on antiretroviral therapy, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Human Immunodeficiency Virus (HIV), Cardiovascular Risk Factor | Phase 2 | Status: RECRUITING